DK1398A - Antifungalt middel, forbindelse til dette, fremgangsmåde til fremstilling af denne og metode til dets anvendelse - Google Patents
Antifungalt middel, forbindelse til dette, fremgangsmåde til fremstilling af denne og metode til dets anvendelseInfo
- Publication number
- DK1398A DK1398A DK199800013A DK1398A DK1398A DK 1398 A DK1398 A DK 1398A DK 199800013 A DK199800013 A DK 199800013A DK 1398 A DK1398 A DK 1398A DK 1398 A DK1398 A DK 1398A
- Authority
- DK
- Denmark
- Prior art keywords
- compound
- preparation
- antifungal agent
- antifungal
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19617495 | 1995-07-08 | ||
JP19617495 | 1995-07-08 | ||
JP9601872 | 1996-07-05 | ||
PCT/JP1996/001872 WO1997002821A2 (en) | 1995-07-08 | 1996-07-05 | Antifungal agent, compound therefor, process for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
DK1398A true DK1398A (da) | 1998-01-07 |
DK176599B1 DK176599B1 (da) | 2008-10-27 |
Family
ID=16353435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK199800013A DK176599B1 (da) | 1995-07-08 | 1998-01-07 | Antifungalt middel, forbindelse til dette, fremgangsmåde til fremstilling af denne og metode til dets anvendelse |
Country Status (22)
Country | Link |
---|---|
US (1) | US5900488A (da) |
EP (1) | EP0839035B1 (da) |
KR (1) | KR100386491B1 (da) |
CN (1) | CN1091596C (da) |
AT (1) | AT407832B (da) |
CA (1) | CA2226214C (da) |
CH (1) | CH692045A5 (da) |
DE (1) | DE19681478B4 (da) |
DK (1) | DK176599B1 (da) |
ES (1) | ES2137888B1 (da) |
FI (1) | FI119357B (da) |
GB (1) | GB2317615B (da) |
HK (1) | HK1009751A1 (da) |
IL (1) | IL122618A (da) |
IN (1) | IN185384B (da) |
LU (1) | LU90190B1 (da) |
NO (1) | NO980055L (da) |
NZ (1) | NZ311796A (da) |
SE (1) | SE9800016L (da) |
TW (1) | TW450969B (da) |
WO (1) | WO1997002821A2 (da) |
ZA (1) | ZA965745B (da) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6127397A (en) * | 1996-12-10 | 2000-10-03 | Nihon Nohyaku Co., Ltd. | Optically active (R)-(E)-(4-substituted-phenyl-1,3-dithiolan-2-ylidene)-1-imidazolylaceto nitrile derivative, antifungal composition comprising the same, and method for producing the same |
ATE521349T1 (de) | 2002-06-18 | 2011-09-15 | Pola Pharma Inc | Antimykotische medizinische zusammensetzungen |
WO2003105903A1 (ja) * | 2002-06-18 | 2003-12-24 | ポーラ化成工業株式会社 | 抗真菌医薬組成物 |
PL2005958T3 (pl) | 2006-03-08 | 2013-11-29 | Nihon Nohyaku Co Ltd | Kompozycja farmaceutyczna do stosowania zewnętrznego |
CA2645110C (en) * | 2006-03-08 | 2013-11-19 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
BRPI0621386B8 (pt) * | 2006-03-08 | 2021-07-13 | Nihon Nihyaku Co Ltd | composição farmacêutica para o uso externo |
ES2588188T3 (es) * | 2007-08-27 | 2016-10-31 | Nihon Nohyaku Co., Ltd. | Agente para la dermatitis fúngica |
JP5529539B2 (ja) * | 2007-09-05 | 2014-06-25 | 株式会社ポーラファルマ | 医薬組成物 |
JP5453093B2 (ja) | 2007-09-05 | 2014-03-26 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
EP2191827B1 (en) | 2007-09-05 | 2013-10-30 | Pola Pharma Inc. | Antifungal composition |
CN102395274B (zh) | 2009-02-13 | 2014-03-12 | 托派卡医药股份有限公司 | 抗真菌制剂 |
KR101409792B1 (ko) | 2009-04-09 | 2014-06-19 | 니혼노야쿠가부시키가이샤 | 항진균성 약제학적 조성물 |
JP5688405B2 (ja) | 2009-04-09 | 2015-03-25 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
CN102481286B (zh) * | 2009-08-25 | 2014-02-26 | 宝丽制药股份有限公司 | 抗真菌药物组合物 |
JP5832451B2 (ja) | 2010-06-11 | 2015-12-16 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
CN103012385B (zh) * | 2012-02-17 | 2015-07-08 | 山东威智医药工业有限公司 | 卢立康唑的晶型及其制备方法 |
EP2895479A1 (en) * | 2012-09-14 | 2015-07-22 | Pola Pharma Inc. | Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal |
RU2622644C2 (ru) * | 2012-09-14 | 2017-06-19 | Пола Фарма Инк. | Кристаллическое вещество и содержащий его фармацевтический препарат |
JP5460797B1 (ja) | 2012-09-14 | 2014-04-02 | 株式会社ポーラファルマ | アミド誘導体及び安定性指標としてのその使用 |
US9068958B1 (en) | 2012-09-14 | 2015-06-30 | Pola Pharma Inc. | Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal |
CN104955455A (zh) * | 2013-01-28 | 2015-09-30 | 宝丽制药股份有限公司 | 针对由病原微生物诸如曲霉引起的疾病的药物组合物 |
US20150352078A1 (en) * | 2013-01-28 | 2015-12-10 | Pola Pharma Inc. | Pharmaceutical composition for diseases caused by pathogenic microorganisms such as candida |
JP5589110B1 (ja) | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
JP5680161B1 (ja) | 2013-09-06 | 2015-03-04 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
JP5587488B1 (ja) | 2013-12-12 | 2014-09-10 | 株式会社ポーラファルマ | ルリコナゾールを含有する製剤の評価方法及び指標物質 |
AR100180A1 (es) * | 2014-04-25 | 2016-09-14 | Syngenta Participations Ag | Derivados de imidazol microbiocidas |
EP3230280A4 (en) * | 2014-12-12 | 2018-05-09 | Glenmark Pharmaceuticals Limited | Process for preparation of luliconazole |
WO2017108972A1 (en) | 2015-12-21 | 2017-06-29 | Laboratorios Lesvi, S.L. | Compounds of r-(-)-(e)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1 -imidazolylacetonitrile-ha (luliconazole-ha) as antifungals |
CN106008166B (zh) * | 2016-05-17 | 2018-09-25 | 上海福乐医药科技有限公司 | 一种手性2-氯-1-(2,4-二氯苯基)乙醇的工业化生产方法 |
US11185548B2 (en) | 2016-12-23 | 2021-11-30 | Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) | Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases |
TR201714882A2 (tr) | 2017-10-03 | 2019-04-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari |
US10898470B1 (en) | 2019-08-13 | 2021-01-26 | Sato Pharmaceutical Co., Ltd. | Pharmaceutical composition containing antifungal agent as active ingredient |
WO2023131969A1 (en) * | 2022-01-09 | 2023-07-13 | Kimia Biosciences Limited | Improved process for the preparation of luliconazole |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0218736B1 (en) * | 1985-10-10 | 1993-04-07 | Nihon Nohyaku Co., Ltd. | A ketene s,s-acetal derivative, a process for manufacturing thereof and a method for curing mycosis by administering it |
DE3587252T2 (de) * | 1985-10-09 | 1993-07-15 | Nihon Nohyaku Co Ltd | Keten-s,s,-acetalderivate, verfahren zu ihrer herstellung und methode zur heilung von mykose unter verwendung dieser derivate. |
JP3030780B2 (ja) * | 1988-12-29 | 2000-04-10 | 日本農薬株式会社 | 光学活性なケテンジチオアセタール誘導体及びその製造方法 |
JPH0386337A (ja) * | 1989-08-28 | 1991-04-11 | Maeda Seisakusho:Kk | エクスパンディングチャックを用いた多重巻締め機および多重巻締め方法 |
CN1038247C (zh) * | 1990-05-16 | 1998-05-06 | 云南省建筑材料科学研究设计院 | 一种新型磷石膏胶结料 |
JP3038519B2 (ja) * | 1992-01-28 | 2000-05-08 | 日本農薬株式会社 | 創傷治癒促進剤 |
-
1996
- 1996-07-05 WO PCT/JP1996/001872 patent/WO1997002821A2/en active IP Right Grant
- 1996-07-05 NZ NZ311796A patent/NZ311796A/xx not_active IP Right Cessation
- 1996-07-05 CH CH00023/98A patent/CH692045A5/de not_active IP Right Cessation
- 1996-07-05 GB GB9726766A patent/GB2317615B/en not_active Expired - Lifetime
- 1996-07-05 ES ES009750013A patent/ES2137888B1/es not_active Expired - Fee Related
- 1996-07-05 CN CN96196659A patent/CN1091596C/zh not_active Expired - Lifetime
- 1996-07-05 IN IN1499DE1996 patent/IN185384B/en unknown
- 1996-07-05 US US08/981,420 patent/US5900488A/en not_active Expired - Lifetime
- 1996-07-05 KR KR10-1998-0700071A patent/KR100386491B1/ko not_active IP Right Cessation
- 1996-07-05 EP EP96922243A patent/EP0839035B1/en not_active Expired - Lifetime
- 1996-07-05 ZA ZA965745A patent/ZA965745B/xx unknown
- 1996-07-05 CA CA002226214A patent/CA2226214C/en not_active Expired - Lifetime
- 1996-07-05 IL IL12261896A patent/IL122618A/en not_active IP Right Cessation
- 1996-07-05 AT AT0906196A patent/AT407832B/de not_active IP Right Cessation
- 1996-07-05 DE DE19681478T patent/DE19681478B4/de not_active Expired - Lifetime
- 1996-07-06 TW TW085108169A patent/TW450969B/zh not_active IP Right Cessation
-
1997
- 1997-12-31 LU LU90190A patent/LU90190B1/de active
-
1998
- 1998-01-06 NO NO980055A patent/NO980055L/no not_active Application Discontinuation
- 1998-01-07 SE SE9800016A patent/SE9800016L/xx not_active Application Discontinuation
- 1998-01-07 FI FI980023A patent/FI119357B/fi not_active IP Right Cessation
- 1998-01-07 DK DK199800013A patent/DK176599B1/da not_active IP Right Cessation
- 1998-09-18 HK HK98110741A patent/HK1009751A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1398A (da) | Antifungalt middel, forbindelse til dette, fremgangsmåde til fremstilling af denne og metode til dets anvendelse | |
IS4483A (is) | Nýtt segavarnarlyf, aðferð við framleiðslu þess og notkun | |
NO20012158D0 (no) | Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav | |
DK1036794T3 (da) | 2-Aryl-8-oxodihydropurinderivater, fremgangsmåde til fremstilling af samme, medicinske præparater indeholdende samme og mellemprodukter deraf | |
NO305833B1 (no) | Naftylforbindelser, mellomprodukter og anvendelse av forbindelsene | |
NO950425L (no) | Antifungale midler, fremgangsmåter for fremstilling av disse, og mellomprodukter | |
NO974572D0 (no) | Cyklodextrin-forbindelser, fremgangsmåter for fremstilling og anvendelse derav | |
DK0622408T3 (da) | Sammensætning og fremgangsmåde til fremstilling af gelatinfrie, bløde kapsler | |
DK0815130T3 (da) | Caseinphosphopeptid, casein indeholdende samme og fremgangsmåde til præparationen deraf | |
NO307707B1 (no) | Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav | |
DK0811006T3 (da) | Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse | |
NO961071D0 (no) | Kjemiske forbindelser, deres fremstilling og anvendelse | |
DK0729956T3 (da) | Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder | |
DK0998473T3 (da) | Krystalmodifikation af et N-phenyl-2-pyrimidinaminderivat, fremgangsmåder til fremstilling deraf samt dets anvendelse | |
NO20003070D0 (no) | Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav | |
DK91793A (da) | Fremgangsmåde til overfladebehandling, midler til udøvelse og anvendelsen heraf | |
DK0831098T3 (da) | Mellemprodukter og fremgangsmåde til fremstilling af olanzapin | |
NO893748L (no) | Forbedret nedslipbart belegg og fremgangsmaate til dets fremstilling. | |
DK1003383T3 (da) | Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf | |
DK432289A (da) | Vandfortyndbart, lufttoerende belaegningsmiddel og dets anvendelse | |
NO990913D0 (no) | Naftylforbindelser, intermediater, sammensetninger og metoder for anvendelse | |
DK60593D0 (da) | Kemiske forbindelser, deres fremstilling og anvendelse | |
DK1061955T3 (da) | Polynukleotidsammensætning, fremstillingsmetode og anvendelse deraf | |
NO975415L (no) | Basiske koboltholdige karbonater, fremgangsmåte for fremstilling og anvendelse derav | |
DK0806949T3 (da) | Ny farmaceutisk komposition, der indeholder trimebutin, og fremgangsmåde til fremstilling deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |
Expiry date: 20180107 |